Dr. Ramit Panara, M.D
NPI: 1407080849
Total Payments
$45,183
2024 Payments
$3,005
Companies
70
Transactions
1,201
Medicare Patients
8,476
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$24,272 (53.7%)
Food & Beverage$20,432 (45.2%)
Travel$303.97 (0.7%)
Education$104.87 (0.2%)
Gifts$70.29 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,272 | 24 | 53.7% |
| Food and Beverage | $20,432 | 1,155 | 45.2% |
| Travel and Lodging | $303.97 | 13 | 0.7% |
| Education | $104.87 | 8 | 0.2% |
| Gift | $70.29 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $26,513 | 179 | $0 (2024) |
| Allergan, Inc. | $1,499 | 53 | $0 (2021) |
| Biogen, Inc. | $1,277 | 76 | $0 (2024) |
| EMD Serono, Inc. | $1,261 | 86 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,199 | 95 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,132 | 79 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $1,067 | 67 | $0 (2024) |
| Amgen Inc. | $921.74 | 42 | $0 (2024) |
| Genentech USA, Inc. | $745.91 | 30 | $0 (2024) |
| GENZYME CORPORATION | $716.87 | 41 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,005 | 175 | ABBVIE INC. ($510.52) |
| 2023 | $8,414 | 143 | ABBVIE INC. ($6,410) |
| 2022 | $15,044 | 177 | ABBVIE INC. ($12,582) |
| 2021 | $10,257 | 196 | AbbVie Inc. ($6,912) |
| 2020 | $2,056 | 128 | Biogen, Inc. ($239.46) |
| 2019 | $2,269 | 136 | EMD Serono, Inc. ($234.03) |
| 2018 | $2,039 | 115 | Amgen Inc. ($240.12) |
| 2017 | $2,099 | 131 | US WorldMeds, LLC ($301.61) |
All Payment Transactions
1,201 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $33.84 | General |
| Category: Musculoskeletal | ||||||
| 12/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/11/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: Neurology | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Neurology | ||||||
| 11/15/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/15/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/14/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: Neurology | ||||||
| 11/12/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.30 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,247 | 15,643 | $1.1M | $341,317 |
| 2022 | 15 | 2,243 | 13,270 | $1.1M | $328,093 |
| 2021 | 14 | 2,008 | 2,553 | $792,377 | $266,683 |
| 2020 | 12 | 1,978 | 2,686 | $870,845 | $254,141 |
Total Patients
8,476
Total Services
34,152
Medicare Billing
$1.2M
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 469 | 736 | $250,498 | $96,013 | 38.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 19 | 12,900 | $240,714 | $63,920 | 26.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 245 | 252 | $167,048 | $34,455 | 20.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 205 | 205 | $70,725 | $33,531 | 47.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 528 | 544 | $131,898 | $33,370 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 222 | 289 | $69,481 | $26,922 | 38.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 200 | 219 | $70,036 | $20,872 | 29.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 160 | 282 | $62,993 | $18,065 | 28.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 21 | 21 | $26,141 | $7,099 | 27.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 104 | 105 | $10,278 | $2,451 | 23.8% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 11 | 25 | $5,545 | $1,485 | 26.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 12 | 14 | $3,830 | $1,069 | 27.9% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 16 | 16 | $2,846 | $711.84 | 25.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 12 | 12 | $2,134 | $533.88 | 25.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 11 | $1,328 | $446.49 | 33.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 12 | 12 | $1,493 | $373.80 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 459 | 736 | $250,498 | $96,305 | 38.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 11 | 10,500 | $195,570 | $51,407 | 26.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 238 | 245 | $162,408 | $38,254 | 23.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 227 | 227 | $78,315 | $35,238 | 45.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 523 | 529 | $128,261 | $31,046 | 24.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 228 | 268 | $85,706 | $22,022 | 25.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 166 | 342 | $76,396 | $19,561 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 173 | $41,593 | $15,326 | 36.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 38 | 38 | $21,708 | $5,487 | 25.3% |
About Dr. Ramit Panara, M.D
Dr. Ramit Panara, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Lake Mary, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1407080849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramit Panara, M.D has received a total of $45,183 in payments from pharmaceutical and medical device companies, with $3,005 received in 2024. These payments were reported across 1,201 transactions from 70 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,272).
As a Medicare-enrolled provider, Panara has provided services to 8,476 Medicare beneficiaries, totaling 34,152 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology, Specialist
- Location Lake Mary, FL
- Active Since 05/13/2009
- Last Updated 02/05/2014
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1407080849
Products in Payments
- UBRELVY (Drug) $19,130
- QULIPTA (Drug) $7,916
- NUPLAZID (Drug) $1,067
- NURTEC ODT (Drug) $786.02
- KESIMPTA (Drug) $782.23
- TYSABRI (Biological) $756.15
- Aimovig (Biological) $721.78
- OCREVUS (Biological) $560.36
- AUBAGIO (Drug) $479.39
- Briviact (Drug) $468.65
- APTIOM (Drug) $399.32
- NAMZARIC (Drug) $354.57
- RYTARY (Drug) $337.81
- TROKENDI XR (Drug) $325.42
- AUSTEDO (Drug) $325.12
- EMGALITY (Drug) $314.27
- INGREZZA (Drug) $288.43
- GOCOVRI (Drug) $277.43
- Xadago (Drug) $266.97
- COPAXONE (Drug) $259.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Lake Mary
Samip Borad, M.b.b.s., Md, Mha, M.B.B.S., MD, MHA
Student in an Organized Health Care Education/Training Program — Payments: $5,792
Student in an Organized Health Care Education/Training Program $5,792
Himabindu Gandam Venkata, M.d.,, M.D.,
Student in an Organized Health Care Education/Training Program — Payments: $4,232
Student in an Organized Health Care Education/Training Program $4,232
Jennifer Kinaga, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $2,935
Student in an Organized Health Care Education/Training Program $2,935
Leslie Andujar, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $951.64
Student in an Organized Health Care Education/Training Program $951.64
Maria Lopez Craig, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $218.09
Student in an Organized Health Care Education/Training Program $218.09
Erynne Bowers, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $177.45
Student in an Organized Health Care Education/Training Program $177.45